Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia
Conclusions
Financial investment in AMM during childhood may be balanced or exceeded across a lifetime by reduced refractive progression, simpler lenses, and reduced risk of pathology and vision loss. Our methodology can be applied to estimate cost in comparable scenarios.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Fricke, T. R., Sankaridurg, P., Naduvilath, T., Resnikoff, S., Tahhan, N., He, M., Frick, K. D. Tags: Open access Review Source Type: research
More News: Australia Health | China Health | Eyes | Myopia (short sighted) | Opthalmology | Pathology | UK Health